| 生物活性 | |||
|---|---|---|---|
| 描述 | Tildacerfont is a potent, orally active CRF1 receptor antagonist. Tildacerfont is effective in reducing ACTH and adrenal androgen levels. Tildacerfont has a favourable safety profile and can be used to study congenital adrenal hyperplasia[1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.38mL 0.48mL 0.24mL |
11.91mL 2.38mL 1.19mL |
23.81mL 4.76mL 2.38mL |
| 参考文献 |
|---|